PT-141 is a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound operates by activating specific receptors across the body, leading to enhanced sexual response. Clinical studies have revealed that PT-141 has the potential to effectively manage a variety of sexual dysfunctions